News | July 14, 2008

Epocrates Drug, Formulary Application Available for iPhone, iPod

July 15, 2008 - Epocrates Inc. announced that its mobile drug and formulary reference, reportedly used by more than 500,000 healthcare professionals, can be downloaded free for the iPhone and iPod touch from the Apple App Store after Epocrates registration.

In addition, for the first time, the Epocrates Rx mobile application will feature pill pictures and a drug identification tool, providing more visual cues and resources for today's busy physicians. With enhanced functionality, clinicians can show their patients pictures of a newly prescribed drug, or identify a patient's existing medication with a physical description (e.g., round, blue and scored) when the name cannot be recalled.

"I believe Epocrates on the iPhone is an essential tool for the medical community - it is the one native application most healthcare professionals cannot live without," said Dr. Michael Salesin, Wayne State University School of Medicine. "Many of my colleagues have been waiting for the Epocrates application before purchasing the iPhone. I guarantee it's going to be the first download on many devices, and immediately put to use with patients."

Epocrates software is used by clinicians worldwide to reference a host of drug information, such as dosing, interactions and health plan coverage.

The Epocrates free application is available from Apple's App Store on iPhone and iPod touch or at www.itunes.com/appstore.

For more information: www.epocrates.com/company


Related Content

News | Pharmaceuticals

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

Home July 10, 2024
Home
News | Pharmaceuticals

June 5, 2024 — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data ...

Home June 05, 2024
Home
News | Pharmaceuticals

May 24, 2024 — Lexicon Pharmaceuticals, Inc. announced a new post-hoc analysis of clinical data showing that INPEFA ...

Home May 24, 2024
Home
News | Pharmaceuticals

May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...

Home May 06, 2024
Home
News | Pharmaceuticals

February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on ...

Home February 16, 2024
Home
News | Pharmaceuticals

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
News | Pharmaceuticals

January 12, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home January 12, 2024
Home
News | Pharmaceuticals

November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home November 21, 2023
Home
Feature | Pharmaceuticals | By Christine Book

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor ...

Home October 25, 2023
Home
Videos | Pharmaceuticals

In this third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at ...

Home September 26, 2023
Home
Subscribe Now